2-Methyl-2-propanyl {(1S,3S)-1-[(2S,4S)-4-isopropyl-5-oxotetrahydro-2-furanyl]-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl}carbamate(CAS: 866030-35-5)

This compound is subject to regulatory guidelines such as GHS for hazardous chemicals, REACH for registration, evaluation, authorization, and restriction of chemicals in the European Union, and FDA/EPA requirements for safety, purity, and environmental impact. Companies must adhere to these regulations for proper handling, storage, and disposal.

There are alternative reagents and synthetic pathways that can be used, such as analogous compounds like (1S,3S)-1-[(2S,4S)-4-isopropyl-5-oxotetrahydro-2-furanyl]-3-(4-methoxybenzyl)-4-methylpentylcarbamate. These alternatives can offer similar functionality but with different chemical structures and potentially lower toxicity or better reactivity.

The market trend for this compound is driven by its use in pharmaceutical applications, particularly as a precursor in drug synthesis. Research trends focus on its potential as a lead compound for new drug development and optimization of synthesis processes to improve yield and reduce cost. Price trends indicate a stable market with potential for growth due to increased demand in the pharmaceutical industry.

Waste containing this compound should be collected in appropriate containers and handled according to GHS guidelines. For disposal, professional waste management services should be used, and incineration or chemical treatment methods may be employed. Environmental precautions include ensuring no release into the environment and following local and national waste disposal regulations.